DE69721749D1 - Eprosartandihydrat und ein verfahren zu seiner herstellung und formulierung - Google Patents
Eprosartandihydrat und ein verfahren zu seiner herstellung und formulierungInfo
- Publication number
- DE69721749D1 DE69721749D1 DE69721749T DE69721749T DE69721749D1 DE 69721749 D1 DE69721749 D1 DE 69721749D1 DE 69721749 T DE69721749 T DE 69721749T DE 69721749 T DE69721749 T DE 69721749T DE 69721749 D1 DE69721749 D1 DE 69721749D1
- Authority
- DE
- Germany
- Prior art keywords
- eprosartand
- dihydrate
- formulation
- production
- eprosartand dihydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1441496P | 1996-03-29 | 1996-03-29 | |
US14414P | 1996-03-29 | ||
PCT/US1997/004877 WO1997036874A1 (en) | 1996-03-29 | 1997-03-26 | Eprosartan dihydrate and a process for its production and formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69721749D1 true DE69721749D1 (de) | 2003-06-12 |
DE69721749T2 DE69721749T2 (de) | 2004-03-25 |
Family
ID=21765344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69721749T Expired - Lifetime DE69721749T2 (de) | 1996-03-29 | 1997-03-26 | Eprosartandihydrat und ein verfahren zu seiner herstellung und formulierung |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP0889880B1 (de) |
JP (1) | JP4316013B2 (de) |
CN (2) | CN1214682A (de) |
AP (1) | AP901A (de) |
AR (1) | AR006439A1 (de) |
AT (1) | ATE239723T1 (de) |
AU (1) | AU726694B2 (de) |
BG (1) | BG64095B1 (de) |
BR (1) | BR9708336A (de) |
CA (1) | CA2250395C (de) |
CZ (1) | CZ293345B6 (de) |
DE (1) | DE69721749T2 (de) |
DK (1) | DK0889880T3 (de) |
DZ (1) | DZ2199A1 (de) |
EA (1) | EA001958B1 (de) |
EG (1) | EG23889A (de) |
ES (1) | ES2198564T3 (de) |
HK (1) | HK1016594A1 (de) |
HU (1) | HU228263B1 (de) |
ID (1) | ID16507A (de) |
IL (1) | IL126319A0 (de) |
MA (1) | MA24437A1 (de) |
MY (1) | MY117682A (de) |
NO (2) | NO311760B1 (de) |
NZ (1) | NZ332008A (de) |
OA (1) | OA11176A (de) |
PL (1) | PL188816B1 (de) |
PT (1) | PT889880E (de) |
RO (1) | RO118870B1 (de) |
SK (1) | SK282346B6 (de) |
TR (1) | TR199801954T2 (de) |
TW (1) | TW434239B (de) |
UA (1) | UA49880C2 (de) |
UY (1) | UY24504A1 (de) |
WO (1) | WO1997036874A1 (de) |
ZA (1) | ZA972686B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262102B1 (en) * | 1997-06-27 | 2001-07-17 | Smithkline Beecham Corporation | Eprosartan monohydrate |
US6558699B2 (en) * | 1997-11-17 | 2003-05-06 | Smithkline Beecham Corporation | High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
AU750611B2 (en) * | 1997-11-17 | 2002-07-25 | Smithkline Beecham Corporation | High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
ID25640A (id) | 1998-03-04 | 2000-10-19 | Takeda Chemical Industries Ltd | Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya |
ZA991922B (en) * | 1998-03-11 | 1999-09-13 | Smithkline Beecham Corp | Novel compositions of eprosartan. |
WO2000004862A2 (en) * | 1998-07-20 | 2000-02-03 | Smithkline Beecham Corporation | Bioenhanced formulations comprising eprosartan in oral solid dosage form |
GB9820405D0 (en) | 1998-09-18 | 1998-11-11 | Smithkline Beecham Plc | Process |
AU1042199A (en) * | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Antihypertensive medicaments containing lacidipine and telmisartan |
AU1157500A (en) * | 1998-11-06 | 2000-05-29 | Boehringer Ingelheim International Gmbh | Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof |
DK1197223T3 (da) * | 1999-04-28 | 2005-05-30 | Takeda Pharmaceutical | Farmaceutisk præparat til forebyggelse, behandling eller udviklingsinhibition af simpel retinopati eller præproliferativ retinopati |
GB9920919D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel compound |
GB9920917D0 (en) | 1999-09-03 | 1999-11-10 | Sb Pharmco Inc | Novel process |
CZ20023381A3 (cs) * | 2000-04-12 | 2003-02-12 | Novartis Ag | Kombinované farmaceutické prostředky obsahující antagonistu AT1-receptoru nebo/a inhibitor HMG-CoA reduktázy nebo/a ACE inhibitor |
AU2002364381A1 (en) * | 2001-11-23 | 2003-06-10 | Solvay Pharmaceuticals Gmbh | Hypertonia treatment during the acute phase of a cerebrovascular accident |
KR100517638B1 (ko) | 2002-04-08 | 2005-09-28 | 주식회사 엘지생명과학 | 게미플록사신 산염의 새로운 제조방법 |
EG24716A (en) | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
RU2004137109A (ru) * | 2002-05-17 | 2005-10-10 | Новартис АГ (CH) | Комбинация блокатора рецептора ангиотензина ii и бетаблокатора для вторичной профилактики инфаркта миокарда |
DE10230272A1 (de) * | 2002-07-05 | 2004-01-22 | Solvay Pharmaceuticals Gmbh | AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen |
EP3045174A1 (de) | 2003-01-31 | 2016-07-20 | Daiichi Sankyo Company, Limited | Medikament zur vorbeugung und behandlung von arteriosklerose und bluthochdruck |
WO2009013760A2 (en) | 2007-07-25 | 2009-01-29 | Hetero Drugs Limited | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
WO2009084028A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate |
CN101333216A (zh) | 2008-08-03 | 2008-12-31 | 浙江华海药业股份有限公司 | 一种新的依普罗沙坦甲磺酸盐成盐工艺 |
CN113354553B (zh) * | 2021-06-03 | 2023-09-15 | 北京宝诺康医药科技有限公司 | 一种甲氧氯普胺单盐酸盐一水合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312828A (en) * | 1989-06-14 | 1994-05-17 | Finkelstein Joseph A | Substituted imidazoles having angiotensin II receptor blocking activity |
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
AU9137791A (en) * | 1990-12-14 | 1992-07-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
-
1997
- 1997-03-26 AT AT97917004T patent/ATE239723T1/de active
- 1997-03-26 NZ NZ332008A patent/NZ332008A/xx not_active IP Right Cessation
- 1997-03-26 HU HU9902769A patent/HU228263B1/hu unknown
- 1997-03-26 RO RO98-01406A patent/RO118870B1/ro unknown
- 1997-03-26 IL IL12631997A patent/IL126319A0/xx active IP Right Grant
- 1997-03-26 EP EP97917004A patent/EP0889880B1/de not_active Expired - Lifetime
- 1997-03-26 UY UY24504A patent/UY24504A1/es not_active IP Right Cessation
- 1997-03-26 BR BR9708336A patent/BR9708336A/pt not_active IP Right Cessation
- 1997-03-26 JP JP53538497A patent/JP4316013B2/ja not_active Expired - Lifetime
- 1997-03-26 SK SK1322-98A patent/SK282346B6/sk not_active IP Right Cessation
- 1997-03-26 WO PCT/US1997/004877 patent/WO1997036874A1/en active IP Right Grant
- 1997-03-26 PL PL97329046A patent/PL188816B1/pl unknown
- 1997-03-26 DE DE69721749T patent/DE69721749T2/de not_active Expired - Lifetime
- 1997-03-26 CZ CZ19983101A patent/CZ293345B6/cs not_active IP Right Cessation
- 1997-03-26 TR TR1998/01954T patent/TR199801954T2/xx unknown
- 1997-03-26 MA MA24539A patent/MA24437A1/fr unknown
- 1997-03-26 AU AU25470/97A patent/AU726694B2/en not_active Expired
- 1997-03-26 AR ARP970101257A patent/AR006439A1/es active IP Right Grant
- 1997-03-26 CA CA002250395A patent/CA2250395C/en not_active Expired - Lifetime
- 1997-03-26 CN CN97193471A patent/CN1214682A/zh active Pending
- 1997-03-26 DK DK97917004T patent/DK0889880T3/da active
- 1997-03-26 PT PT97917004T patent/PT889880E/pt unknown
- 1997-03-26 UA UA98095006A patent/UA49880C2/uk unknown
- 1997-03-26 ES ES97917004T patent/ES2198564T3/es not_active Expired - Lifetime
- 1997-03-26 EA EA199800873A patent/EA001958B1/ru not_active IP Right Cessation
- 1997-03-27 EG EG24497A patent/EG23889A/xx active
- 1997-03-27 ZA ZA9702686A patent/ZA972686B/xx unknown
- 1997-03-27 MY MYPI97001335A patent/MY117682A/en unknown
- 1997-03-27 AP APAP/P/1997/000956A patent/AP901A/en active
- 1997-03-29 DZ DZ970046A patent/DZ2199A1/fr active
- 1997-03-31 ID IDP971059A patent/ID16507A/id unknown
- 1997-06-17 TW TW086108370A patent/TW434239B/zh not_active IP Right Cessation
-
1998
- 1998-09-28 NO NO19984503A patent/NO311760B1/no not_active IP Right Cessation
- 1998-09-29 OA OA9800184A patent/OA11176A/en unknown
- 1998-10-07 BG BG102822A patent/BG64095B1/bg unknown
-
1999
- 1999-04-13 HK HK99101567A patent/HK1016594A1/xx not_active IP Right Cessation
-
2001
- 2001-06-09 CN CN01121133A patent/CN1332167A/zh active Pending
-
2002
- 2002-07-19 NO NO2002005C patent/NO2002005I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69721749D1 (de) | Eprosartandihydrat und ein verfahren zu seiner herstellung und formulierung | |
DE69532895D1 (de) | Biomaterial und verfahren zu dessen herstellung | |
DE69716129D1 (de) | Seitlich ausdehnbarer tampon und verfahren zu seiner herstellung | |
DE69929311D1 (de) | Oximanderivate und verfahren zu ihrer herstellung | |
DE69710484D1 (de) | Übergezogene süsswaren und verfahren zu deren herstellung | |
ATE216704T1 (de) | Propiophenonderivate und verfahren zu ihrer herstellung | |
DE69504892D1 (de) | Mischelement und Verfahren zu dessen Herstellung | |
DE69922815D1 (de) | Gipsplatte und verfahren zu ihrer herstellung | |
DE69930254D1 (de) | Mikroströmungstechnischer gebenstand und verfahren zu seiner herstellung | |
ATE379971T1 (de) | Disinfektionsmittel und verfahren zu dessen herstellung | |
DE69529065D1 (de) | Härtbare zusammensetzung und verfahren zu ihrer herstellung | |
DE69731059D1 (de) | Gebäudeeinheit, modulare gebäudekunstruktion und verfahren zu seiner herstellung | |
DE69729941D1 (de) | Beschleunigungsmesselement sowie verfahren zu seiner herstellung | |
DE69611599D1 (de) | Halbaromatische polyamidzusamensetzung und verfahren zu ihrer herstellung | |
DE69942382D1 (de) | Sensor und verfahren zu dessen herstellung | |
DE59800305D1 (de) | Formteil und verfahren zu seiner herstellung | |
DE69524599D1 (de) | Antiblockmittel und verfahren zu seiner herstellung | |
DE69628237D1 (de) | Polyestergegenstand und verfahren zu seiner herstellung | |
DE69603829D1 (de) | Schalwandler und verfahren zu dessen herstellung | |
DE69524684D1 (de) | Photosensor und Verfahren zu dessen Herstellung | |
DE59803104D1 (de) | Messwertaufnehmer und ein verfahren zu dessen herstellung | |
DE69941258D1 (de) | Polyisocyanat und verfahren zu seiner herstellung | |
DE69625176D1 (de) | Camptothecin-derivate und verfahren zu ihrer herstellung | |
DE69905326D1 (de) | Sollerschlitz und Verfahren zu dessen Herstellung | |
DE69801795D1 (de) | Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |